Secretary Kerry, the world is on fire, the threats are real, and you can’t work any harder. Even while firefighting, you're giving your first big development policy speech tomorrow, at USAID's Frontiers in Development Forum.
CGD and the Brookings Institution recently released the third edition of the Quality of Official Development Assistance (QuODA), a joint venture that measures donor performance across a series of aid quality indicators to encourage governments, institutions, and agencies to disburse more effective, transparent, and efficient assistance.
I never cease to be astonished by the amount of energy people put into claiming that Randomized Control Trials (RCTs) are the be-all and end-all of impact evaluation methods; nor at the energy people put into claiming that RCTs are marginal, costly, and a waste of time.
Cost-effectiveness studies compare the costs and benefits of different interventions with the aim of improving decisions on the allocation of scarce resources for health. Or, put simply, they allow policy-makers to set priorities for health spending and consider how the next dollar available can get more health for the money.